Agenus | AGEN - Себестоимость





Себестоимость Изменить Дата
AbbVie USD 4.29B 73M 2026-06
Agenus USD 642K 399K 2025-09
Amgen USD 1.87B 271M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Celldex Therapeutics USD 54.2M 8.94M 2025-06
CSL USD 3.87B 2.08B 2025-12
Eli Lilly USD 3.27B 309M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Glaxosmithkline GBP 1.88B 1.6B 2026-03
Incyte USD 104.96M 457K 2026-06
Intrexon USD 1.01M 344K 2024-06
J&J USD 8B 67M 2026-06
Jiangsu Hengrui CNY 1.02B 68.56M 2026-06
Karyopharm Therapeutics USD 1.34M 139K 2026-03
MacroGenics USD 9.53M 585K 2026-03
Merck EUR 2.27B 199M 2026-06
Merck USD 3.14B 200M 2026-06
Novartis USD 3.71B 251M 2026-06
Novavax USD 22.1M 608K 2025-12
Pfizer USD 4.09B 498M 2026-06
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 42.19M 3.7M 2026-06